Hantavirus vs Flu vs COVID: How to Tell the Difference in the First 72 Hours

The three diseases at the 72-hour mark

By 72 hours into a viral respiratory illness, all three diseases look broadly similar: fever, fatigue, body aches, headache, sometimes gastrointestinal symptoms. The differences that matter are subtle in symptoms and obvious in context. The framework below covers the discriminators clinicians actually use.

Fever pattern

Flu: Onset is typically sudden. Temperatures of 38-40°C (100-104°F). Usually peaks in the first 24-48 hours, then begins declining by day 3-5 even without treatment.

COVID: More variable. Can be high or surprisingly low. Often follows a biphasic pattern: initial fever for 3-5 days, then apparent improvement, then in some patients a second deterioration around day 7-10.

Hantavirus: Usually high fever (38.5-40°C). Persistent through phase 1 (days 1-4). Does NOT decline early. If anything, the patient's condition continues deteriorating after day 4 rather than improving.

Muscle pain

Flu: Generalized body aches. Distributed across many muscle groups. Often described as "feeling like I got hit by a truck" with no specific localization.

COVID: Variable. Sometimes severe body aches, sometimes minimal. Often described as fatigue more than pain.

Hantavirus: Distinctly localized. Severe pain in large muscle groups, especially thighs, hips, lower back. Patients often specifically mention these areas without prompting. The pain is described as deep, severe, and different in character from typical flu aches.

This is one of the most useful early discriminators. Asking specifically "where do your muscles hurt" rather than accepting "my body aches" reveals the pattern.

Respiratory symptoms

Flu: Cough and sore throat typically appear in the first 1-2 days. Mild to moderate. Productive or dry cough.

COVID: Cough is very common, especially dry cough. Often appears in the first 1-3 days. Loss of taste/smell was characteristic of early variants but less common with recent strains. Shortness of breath in some cases.

Hantavirus: Absent or minimal during the first 3-4 days. This is one of the most important diagnostic features. A patient with high fever and severe muscle aches but clear lungs and no cough has a hantavirus possibility that must not be missed. Cough and shortness of breath appearing on day 4-7 is the danger sign that marks the transition to severe disease.

Gastrointestinal symptoms

Flu: Possible but not prominent. Nausea or mild abdominal discomfort in some cases, more often in children.

COVID: Variable. Some cases present primarily with GI symptoms. Diarrhea is reported in 10-20% of cases depending on variant.

Hantavirus: Approximately half of patients have prominent GI symptoms in phase 1, including nausea, vomiting, abdominal pain, and diarrhea. This can mislead diagnosis toward food poisoning or viral gastroenteritis. The combination of severe muscle aches plus GI symptoms in the absence of obvious food source is a hantavirus consideration.

Day 4-7 trajectory

This is where the diseases diverge dramatically.

Flu: Most patients are improving by day 5-7. Fever has typically resolved or is mild. Energy is returning. Full recovery within 7-14 days.

COVID: Most patients are improving by day 5-7. Some patients (a minority) experience a second wave of worsening symptoms around day 7-10, sometimes including respiratory deterioration. This is the window when hospitalization risk is highest for COVID.

Hantavirus: Patients are typically getting WORSE, not better. Fever persists. New respiratory symptoms appear: cough, shortness of breath, chest tightness. Heart rate rises. Oxygen saturation begins dropping. The transition from phase 1 (flu-like) to phase 4 (cardiopulmonary failure) can happen within 24 hours of the first respiratory symptoms.

The day 4-7 trajectory is the single most useful discriminator. Improving = probably flu or COVID. Worsening with new respiratory symptoms = hantavirus emergency.

Context: exposure history

Beyond symptoms themselves, the exposure history determines pre-test probability for each diagnosis.

Recent rodent exposure

Time spent in rodent-infested spaces in the past 1-8 weeks is the dominant risk factor for hantavirus. This includes:

• Cleaning cabins, sheds, attics, garages, or seasonal buildings
• Camping in rural areas with active rodent populations
• Working in agricultural settings (grain storage, barns, feedlots)
• Construction work in older buildings with rodent activity
• Living in homes with known rodent infestation

A patient with rodent exposure history and flu-like symptoms should have hantavirus testing ordered, even if other features look more like flu or COVID. This is CDC guidance and applies broadly across endemic regions.

Recent travel

Travel to Argentina, Chile, Uruguay, or other Andes virus regions in the past 1-8 weeks raises the suspicion for Andes virus exposure. Travel to East Asia raises suspicion for Hantaan-related strains. Travel to Northern Europe raises suspicion for Puumala.

For the 2026 MV Hondius cluster specifically, recent travel on the ship or close contact with passengers is a critical exposure marker.

Sick contacts

For COVID and flu, sick contacts in the household, workplace, or social circle in the past 14 days raise suspicion. These illnesses spread efficiently between people.

For hantavirus, sick contacts are essentially never a risk factor EXCEPT for Andes virus in specific situations. A household member with confirmed Andes virus in the symptomatic phase is a real exposure. A coworker who recently had flu is not a hantavirus risk regardless.

Seasonal context

Flu and COVID have seasonal peaks in temperate regions (late fall through early spring). A patient with flu-like symptoms in August in a temperate region has lower pre-test probability for these two diseases.

Hantavirus is more loosely seasonal. Sin Nombre cases peak in spring and early summer (when reservoir mouse populations are highest). Puumala has multi-year cycles. The seasonal pattern is real but less pronounced than for influenza.

What to actually do at 72 hours

The framework above is for orientation. Translating it into action depends on what you find.

If symptoms are improving, no respiratory issues, no exposure history

Probably routine viral illness. Continue rest and hydration. Reassess in 24 hours.

If symptoms persist but are mild, no respiratory issues

Could be any of the three. Get tested for flu and COVID if convenient (rapid tests are widely available). Hantavirus testing is only ordered if there is exposure history; routine outpatient testing is not typical.

If you had rodent exposure or relevant travel history

Call a healthcare provider and explicitly mention the exposure history. Ask whether hantavirus testing is appropriate. Even if testing is negative at 72 hours (often the case before viral load is detectable), the conversation puts hantavirus on the radar for the days ahead.

The Argentine and Chilean health systems have well-established protocols for evaluating possible hantavirus exposure. Most US emergency departments and primary care offices in western states are familiar with the disease. Outside these regions, you may need to advocate more actively for testing consideration.

If you have ANY new respiratory symptoms (cough, shortness of breath, chest tightness)

This is the threshold for emergency evaluation regardless of other features. Severe COVID, severe flu, and hantavirus all become medical emergencies at this point. Go to an emergency department. Mention any rodent exposure history explicitly to the triage nurse.

If you are deteriorating rapidly

Call emergency services. Time matters for all three diseases but most dramatically for hantavirus, where the window between mild respiratory symptoms and respiratory failure can be hours.

What clinicians look for

If you understand the framework above, you can advocate for yourself effectively with healthcare providers. The specific findings that increase clinical suspicion for hantavirus over flu or COVID:

• Persistent high fever past day 4 without respiratory symptoms
• Severe localized muscle pain (thighs, hips, back) disproportionate to systemic symptoms
• Recent rodent exposure or travel to endemic regions
• Laboratory findings: elevated hematocrit, thrombocytopenia, elevated lactate dehydrogenase, immature white blood cells on smear
• Chest X-ray showing bilateral interstitial infiltrates (in the pulmonary phase)
• Rapid clinical deterioration with respiratory failure

These findings, especially combined, prompt hantavirus testing and aggressive supportive care planning. If you have several of these features and your provider has not considered hantavirus, asking explicitly is appropriate.

The honest summary

In the first 72 hours, hantavirus is genuinely difficult to distinguish from flu or COVID by symptoms alone. The discriminators that work are context (exposure history, travel, season) and trajectory (whether symptoms are improving or worsening at day 4-7).

For most people with flu-like symptoms in a non-endemic region with no rodent exposure, hantavirus is so unlikely that it should not weigh on the decision making. Flu and COVID are dramatically more common, and treating early flu-like illness as if it might be hantavirus would be paralyzing.

For people with relevant exposure history or in endemic regions, hantavirus deserves explicit consideration. The cost of mentioning exposure history to your healthcare provider is essentially zero. The benefit of early consideration in the rare case it matters is enormous, because the survival difference between early-recognized hantavirus and late-recognized hantavirus is measured in tens of percentage points of mortality.

The summary is simple: most flu-like illness is flu or COVID. A small subset is hantavirus. Knowing the discriminators and the context that raises suspicion is the difference between routine care and a possibly life-saving conversation with a clinician.